assessed p‐tau217 and NfL in an unselected memory clinic cohort, showing strong utility of p‐tau217 for AD diagnosis and describing biomarker profiles (high/low p‐tau217 and NfL) across clinical groups.17 The gene discussed is NEFL; the disease is Alzheimer disease.